Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Decreasing the adverse effects of cancer therapy: an NCI Workshop on the preclinical development of radiation injury mitigators/protectors.

Literature DB >> 21883022

Decreasing the adverse effects of cancer therapy: an NCI Workshop on the preclinical development of radiation injury mitigators/protectors.

Julie L Ryan¹, Sunil Krishnan, Benjamin Movsas, C Norman Coleman, Bhadrasain Vikram, Stephen S Yoo.

Abstract

Entities: CellLine Chemical Disease Species

Mesh：

Substances：

Year: 2011 PMID： 21883022 PMCID： PMC3322662 DOI： 10.1667/rr2704.1

Source DB: PubMed Journal: Radiat Res ISSN： 0033-7587 Impact factor: 2.841

× No keyword cloud information.

9 in total

1. Does amifostine have a role in chemoradiation treatment?

Authors: David M Brizel; Jens Overgaard
Journal: Lancet Oncol Date: 2003-06 Impact factor: 41.316

2. Radiation dose reduction by cysteine.

Authors: H M PATT; S H MAYER; R L STRAUBE; E M JACKSON
Journal: J Cell Comp Physiol Date: 1953-12

3. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003.

Authors: Helen B Stone; John E Moulder; C Norman Coleman; K Kian Ang; Mitchell S Anscher; Mary Helen Barcellos-Hoff; William S Dynan; John R Fike; David J Grdina; Joel S Greenberger; Martin Hauer-Jensen; Richard P Hill; Richard N Kolesnick; Thomas J Macvittie; Cheryl Marks; William H McBride; Noelle Metting; Terry Pellmar; Mary Purucker; Mike E Robbins; Robert H Schiestl; Thomas M Seed; Joseph E Tomaszewski; Elizabeth L Travis; Paul E Wallner; Mary Wolpert; Daniel Zaharevitz
Journal: Radiat Res Date: 2004-12 Impact factor: 2.841

4. NIAID/NIH radiation/nuclear medical countermeasures product research and development program.

Authors: Nathaniel Hafer; David Cassatt; Andrea Dicarlo; Narayani Ramakrishnan; Joseph Kaminski; Mai-Kim Norman; Bert Maidment; Richard Hatchett
Journal: Health Phys Date: 2010-06 Impact factor: 1.316

Review 5. Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators.

Authors: Benjamin Movsas; Bhadrasain Vikram; Martin Hauer-Jensen; John E Moulder; Ethan Basch; Stephen L Brown; Lisa A Kachnic; Adam P Dicker; C Norman Coleman; Paul Okunieff
Journal: Clin Cancer Res Date: 2010-11-03 Impact factor: 12.531

Review 6. Radiation countermeasure agents: an update.

Authors: Francis Dumont; Antoine Le Roux; Pierre Bischoff
Journal: Expert Opin Ther Pat Date: 2010-01 Impact factor: 6.674

7. Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis. report of an NIAID Workshop, March 26-27, 2007.

Authors: Andrea L DiCarlo; Richard J Hatchett; Joseph M Kaminski; G David Ledney; Terry C Pellmar; Paul Okunieff; Narayani Ramakrishnan
Journal: Radiat Res Date: 2008-06 Impact factor: 2.841

8. Medical countermeasures against nuclear threats: radionuclide decorporation agents.

Authors: David R Cassatt; Joseph M Kaminski; Richard J Hatchett; Andrea L DiCarlo; Jessica M Benjamin; Bert W Maidment
Journal: Radiat Res Date: 2008-10 Impact factor: 2.841

Review 9. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients.

Authors: B Rubio-Viqueira; M Hidalgo
Journal: Clin Pharmacol Ther Date: 2008-11-12 Impact factor: 6.875

9 in total

Review 1. Ionizing radiation: the good, the bad, and the ugly.

Authors: Julie L Ryan
Journal: J Invest Dermatol Date: 2012-01-05 Impact factor: 8.551

2. Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.

Authors: Pataje G S Prasanna; Deepa Narayanan; Kory Hallett; Eric J Bernhard; Mansoor M Ahmed; Gregory Evans; Bhadrasain Vikram; Michael Weingarten; C Norman Coleman
Journal: Radiat Res Date: 2015-08-18 Impact factor: 2.841

Decreasing the adverse effects of cancer therapy: an NCI Workshop on the preclinical development of radiation injury mitigators/protectors.

1. Does amifostine have a role in chemoradiation treatment?

2. Radiation dose reduction by cysteine.

3. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003.

4. NIAID/NIH radiation/nuclear medical countermeasures product research and development program.

Review 5. Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators.

Review 6. Radiation countermeasure agents: an update.

7. Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis. report of an NIAID Workshop, March 26-27, 2007.

8. Medical countermeasures against nuclear threats: radionuclide decorporation agents.

Review 9. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients.

Review 1. Ionizing radiation: the good, the bad, and the ugly.

2. Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.

Review 3. Mouse models for radiation-induced cancers.

4. Normal tissue protection for improving radiotherapy: Where are the Gaps?

Review 5. 2013 Dade W. Moeller lecture: medical countermeasures against radiological terrorism.

Review 6. Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review.

7. Amifostine Prophylaxis in Irradiated Breast Reconstruction: A Study of Oncologic Safety In Vitro.

Review 8. Radiation-induced myeloid leukemia in murine models.

Review 9. Vitamin E Analogs as Radiation Response Modifiers.